LUP Statistics
Record
- Title
- The risk of malignancy is not increased in patients with multiple sclerosis treated with subcutaneous interferon beta-1a: analysis of data from clinical trial and post-marketing surveillance settings.
- Type
- Journal Article
- Publ. year
- 2011
- Author/s
- Sandberg Wollheim, Magnhild; Kornmann, Gabrielle; Bischof, Dorina; Moraga, Margaretha Stam et al.
- Department/s
- Neurology, Lund
- In LUP since
- 2016-04-01
Downloads
| Total | This Year | This Month |
| 569 | 6 | 0 |
United States of America  |
266 (47%) |
Germany  |
121 (21%) |
China  |
29 (5%) |
United Kingdom of Great Britain and Northern Ireland  |
20 (4%) |
France  |
12 (2%) |
India  |
11 (2%) |
Sweden  |
11 (2%) |
Switzerland  |
10 (2%) |
Hong Kong (China)  |
8 (1%) |
Russian Federation  |
7 (1%) |
Canada  |
6 (1%) |
Netherlands (Kingdom of the)  |
6 (1%) |
Ukraine  |
6 (1%) |
Thailand  |
5 (1%) |
Spain  |
5 (1%) |
Italy  |
4 (1%) |
Singapore  |
4 (1%) |
Saudi Arabia  |
3 (1%) |
Denmark  |
3 (1%) |
Finland  |
2 (0%) |
Taiwan (China)  |
2 (0%) |
Poland  |
2 (0%) |
Hungary  |
2 (0%) |
Ireland  |
2 (0%) |
South Africa  |
2 (0%) |
Egypt  |
1 (0%) |
Portugal  |
1 (0%) |
Australia  |
1 (0%) |
Indonesia  |
1 (0%) |
Malaysia  |
1 (0%) |
European Union location  |
1 (0%) |
Algeria  |
1 (0%) |
Tanzania, the United Republic of  |
1 (0%) |
Brazil  |
1 (0%) |
Turkiye  |
1 (0%) |
Lebanon  |
1 (0%) |
Iraq  |
1 (0%) |
Albania  |
1 (0%) |
Japan  |
1 (0%) |
Czechia  |
1 (0%) |
Norway  |
1 (0%) |
Philippines  |
1 (0%) |
South Korea  |
1 (0%) |
Austria  |
1 (0%) |
Iceland  |
1 (0%) |